Bracket expert gives advice ahead of March Madness
University of Illinois professor Sheldon Jackson is a bracket expert who runs bracket odds at U of I.
In the run-up to the 2026 midterm elections, the political parties in many states are working to redefine their congressional district maps to gain every possible edge. From California and Texas to Tennessee and Virginia, redistricting efforts have taken center stage. The Supreme Court has sanctioned partisan gerrymandering, and the system has evolved to one in which state legislature majorities get to determine who is most likely to fill those seats in Congress.
In short, gerrymandering has become a central feature of the system, not a bug. But what if we rethink the structure entirely?
For years, remote work has been viewed as one of the most important drivers of employee satisfaction. New research suggests that assumption may be giving remote work too much credit.
A study published in the INFORMS journal Management Science found that while remote employees often report higher job satisfaction, much of that advantage disappears when researchers account for factors such as workplace culture, trust in management, communication and opportunities for professional development.
A new study from INFORMS suggests warehouse robots perform better when they work together instead of operating independently.
An audio journey of how data and analytics save lives, save money and solve problems.

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
University of Illinois professor Sheldon Jackson is a bracket expert who runs bracket odds at U of I.
Gov. Brian Kemp is set to give an update on distributing the coronavirus vaccine in Georgia. Kemp and other state leaders are scheduled to speak starting at 4 p.m. from the State Capitol.
Loosening restrictions and the warmer weather are beginning to draw students outside where experts say gathering is safer — but still not risk free.
Tens of millions of people across the U.S. have received a coronavirus vaccine. So far, the majority of doses have been either the Moderna or Pfizer vaccine, both of which use mRNA to generate an immune response. These gene-based vaccines have been in the works for decades, but this is the first time they have been used widely in people.
The various Covid-19 vaccines currently being distributed around the globe have the potential to end the worst pandemic in a century. They also will mean hundreds of billions dollars in sales for the pharmaceutical companies that make them.

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine